Pricing Sign in

Made In Tracker

Made In Tracker EasyUDI

Legal

Privacy Policy Legal Notice

About

About FAQ Partners Contact

Our data is continuously updated and sourced from EUDAMED, the European database for medical devices and in vitro diagnostics.

Subscribe to our monthly newsletter:

By subscribing, you accept the General Personal Data Protection Policy.

NeoBorocillina Gola Junior Spray — 1 UDI-DI variant, MDD

MD Atlas
Labomar S.p.A.

Data from EUDAMED, last updated May 30, 2026

NeoBorocillina Gola Junior Spray

B-FTP055EW

1 UDI-DI variant

MDD [Directive 93/42/EEC on medical devices]Class IIa

Legislation: MDD [Directive 93/42/EEC on medical devices]
Risk class: Class IIa
Manufacturer: Labomar S.p.A.

Sign in to open the EUDAMED record

The link to the official EUDAMED page is reserved for signed-in users. Create a free account to continue.

Email

Password

No account yet?

UDI-DI variants

1 UDI-DI variant

Sign in to export

Exports are reserved for signed-in users. Sign in or create an account to continue.

Email

Password

No account yet?

Export results

Applied filters

basicUdiUlid01HEAQD7F224CV32X014M0YGJX

Format

Summary

29 columns included

Trade name
Basic UDI-DI
UDI-DI code
Risk category
Applicable legislation
Status
Organization name
SRN
Reference / catalog number
Additional product description
Intended medical purpose
Placed on the market (country)
Market info update date
Sterile
Single use
Contains latex
Reprocessed single-use
Direct marking
CMR substance
Endocrine disruptor
Annex XVI applicable
Sterilization
OEM applicable
EMDN codes
Last updated
Basic UDI-DI device name
Basic UDI-DI device model
Basic UDI-DI implantable
Basic UDI-DI reagent

FTP055D-FTP055EW

Device characteristics

No device characteristics flagged

Legacy certificates

Certificate number: EPT 0477.MDD.20/3830
Type: refdata.legacy.mdd-certificate-type.ii-excluding-4
Notified body: Eurofins Product Testing Italy S.r.l. (0477)
Validity: Jan 31, 2024

Identity & classification

Basic UDI-DI: B-FTP055EW
Device name: NeoBorocillina Gola Junior Spray
Issuing agency: EUDAMED
Legislation: MDD [Directive 93/42/EEC on medical devices]
Risk class: Class IIa
Version date: Nov 3, 2023

Manufacturer & authorised representative

Manufacturer

Name: Labomar S.p.A.
SRN: IT-MF-000007965
Country: Italy
Email: regulatoryMD@labomar.com
Phone: +3904227312

Variants by status